Navigation Links
CytRx Announces Clinical Results from Its Rising Multiple Dose,Trial with Arimoclomol for ALS

nts and patent applications that were filed from 1998 to 2006 in the areas of RNAi target sequences, RNAi chemistry and RNAi delivery. The Company was founded by CytRx and RNAi pioneers Craig Mello, Ph.D., 2006 Nobel Laureate for discovering RNAi and inventing RNAi therapeutics; Tariq M. Rana, Ph.D., inventor of fundamental technology for stabilizing RNAi and of RNAi nanotransporters; Greg Hannon, Ph.D., discoverer of RNAi mechanism (RISC) and short hairpin RNAi (shRNAi); and Michael Czech, Ph.D., a leader in the application of RNAi to diabetes and obesity. RXi's CEO, Tod Woolf, Ph.D., previously co-invented and commercialized STEALTH(TM) RNAi, one of the most widely used second-generation RNAi research products.

Forward-Looking Statements

This press release may contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Such statements involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements, including risks or uncertainties regarding regulatory approvals for future clinical testing of arimoclomol, including CytRx's planned Phase IIb clinical trial, and the scope of the clinical testing that may be required by regulatory authorities for arimoclomol, uncertainties regarding the timing and amount of revenues, if any, that will be realized by CytRx from the commercialization of arimoclomol, the significant time and expense that will be incurred in developing any of the potential commercial applications for arimoclomol and the potential need for additional capital to fund the development of arimoclomol, as well as other risks or uncertainties described in CytRx's most recently filed SEC documents, such as its most recent annual report on Form 10-K and any current reports on Form 8-K filed since the date of the last Form 10-K. All forward-looking statements are based upon information avail
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
2. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
3. CytRx Announces Positive Results of Arimoclomol in Preclinical Stroke Recovery Studies
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:12/17/2009)... Decision Resources, one of the world,s ... healthcare issues, finds that the cost of Roche/Chugai,s ... side-effect profile, are cited most frequently by surveyed ... Avastin for non-small-cell lung cancer treatment in Germany, ... The new Special European Physician & Payer Forum ...
(Date:12/17/2009)... MedX Limited, the manufacturer and global distributor of ... subsidiary of WellTek Incorporated (OTC Bulletin Board: WTKN), ... exercise and medical machines to ... India, Scotland, South Korea, Spain and Switzerland. ... be used in various medical rehabilitation and fitness ...
(Date:12/17/2009)... Inc., (OTC Bulletin Board: SCIE) disclosed today that its ... letter to shareholders: ,, As the end of the ... the recent closing of a $4.3 million round of ... ramping our business performance as we head into 2010. ... force. We are increasing our sales and marketing activities ...
Breaking Medicine Technology:Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer 2Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer 3WellTek Subsidiary MedX Limited Increases Presence in Global Market 2WellTek Subsidiary MedX Limited Increases Presence in Global Market 3WellTek Subsidiary MedX Limited Increases Presence in Global Market 4SpectraScience Releases Shareholder Newsletter 2SpectraScience Releases Shareholder Newsletter 3SpectraScience Releases Shareholder Newsletter 4SpectraScience Releases Shareholder Newsletter 5Chinese Scientists Develop Database on the Liver 61322 1Elsevier pilots new research tool Reflect in its premier life science journal Cell 10722 1Elsevier pilots new research tool Reflect in its premier life science journal Cell 10722 2Many Kids Feel Threatened in the Classroom 61317 1Many Kids Feel Threatened in the Classroom 61317 2
(Date:12/17/2009)... the particle might someday ease accompanying lung infections , , ... severe pneumonia when infected with the swine flu virus, ... why. , A key to the severity of the ... (TH17), which helps the immune system fight off germs ... in swine-flu patients at 10 Spanish hospitals last summer ...
(Date:12/17/2009)... to announce its newly redesigned Web site: www.psanj.com . PSANJ ... Area often featured in publications such as New York magazine and ... ... December 17, 2009 -- Plastic Surgery Arts of New Jersey (PSANJ) ... . PSANJ is a leading cosmetic surgery center in the New ...
(Date:12/17/2009)... ,for the R&D Informatics Industry, , ... ... Institute is pleased to announce the participation of seven world ... Systems conference to be held on February 3-5, 2010 at ... meeting has been integrated in the Informatics Channel at CHI,s ...
(Date:12/17/2009)... hired Deirdre Byrne to lead the firm’s Interim Leadership division as ... experience in healthcare consulting, Byrne will assume her duties at B. ... ... 17, 2009 -- B. E. Smith recently hired Deirdre ... president. A seasoned executive with nearly 20 years of experience in ...
(Date:12/17/2009)... customary for the holidays to wreak havoc on healthy ... workouts often get short-changed and nutrition is left to ... Waters, it is not impossible to enjoy the holidays ... Raisins and Waters have teamed up to offer advice ... season and get a jump start on New Year,s ...
Breaking Medicine News(10 mins):Health News:Plastic Surgery Arts of New Jersey (PSANJ) Launches New Web Site 2Health News:Plastic Surgery Arts of New Jersey (PSANJ) Launches New Web Site 3Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 2Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 3Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 2Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 3Health News:Celebrity Fitness Trainer Valerie Waters and California Raisins Offer Advice on How to Jump Start the New You in the New Year 2Health News:Celebrity Fitness Trainer Valerie Waters and California Raisins Offer Advice on How to Jump Start the New You in the New Year 3
... objectives in 30 states, particularly in the areas of ... The state of the economy did not deter ... million in grants at its fourth-quarter board meeting in ... in grants for 2008 as a whole, the most ...
... Medical Center has been verified as a Level I Trauma Center-Pediatric by ... , ... Washington, DC (Vocus) February 11, 2009 -- Children,s National Medical ... the Committee on Trauma of the American College of Surgeons (ACS). Children,s ...
... to Be Held at 9:00 A.M. - EXTON, Pa., ... fourth quarter and year end financial results for 2008 are ... the open of the U.S. financial markets.The company will host ... Eastern Time on the same day. During the conference ...
... recent study conducted by researchers at Wake Forest University ... abilities drop as average blood sugar levels rise in ... in this month,s issue of Diabetes Care . ... sub-study of the Action to Control Cardiovascular Risk in ...
... 11 Mesa Laboratories, Inc. (Nasdaq: ... Directors has declared a regular quarterly cash dividend ... payable on March 16, 2009 to shareholders of ... 27, 2009.Mesa Laboratories develops, acquires, manufactures and markets ...
... Emageon Inc. (Nasdaq:, EMAG ), a leader ... health care networks, announced today that it has ... Board: HSSO) that it does not,expect that Stanford ... to consummate the parties, merger transaction today. ...
Other Medicine News:Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 2Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 3Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 4Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 5Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 6Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 7Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 8Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 9Health News:Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 10Health News:Children's National Medical Center Trauma Center Receives Highest Verification from American College of Surgeons 2Health News:ViroPharma to Release 2008 Fourth Quarter and Full Year Financial Results on February 24, 2009 2Health News:Higher blood sugar levels linked to lower brain function in diabetics, study shows 2Health News:Emageon Provides Update Regarding Merger Transaction 2Health News:Emageon Provides Update Regarding Merger Transaction 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: